Gastrointestinal Stromal Tumors
|
0.010 |
Biomarker
|
group |
BEFREE |
Clinically, high NCCN risk GISTs had significantly higher mean expression levels of nuclear phospho-KIT and NFKBIB as compared with those of intermediate or low/very low-risk GISTs.
|
31363162 |
2019 |
Rheumatoid Arthritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
In total, 25 single nucleotide polymorphisms were found to be associated with anti-TNF treatment response in RA (19 from genome-wide association studies and 6 from the meta-analyses), and these map to genes involved in T cell function, NFκB and TNF signalling pathways (including CTCN5, TEC, PTPRC, FCGR2A, NFKBIB, FCGR2A, IRAK3).
|
28607508 |
2017 |
Influenza
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Upregulation of miRNA-4776 in Influenza Virus Infected Bronchial Epithelial Cells Is Associated with Downregulation of NFKBIB and Increased Viral Survival.
|
28448456 |
2017 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings suggested that miR-20a could promote activation of the NFκB pathway and downstream targets livin and survivin by targeting NFKBIB, which potentially contributed to GC chemoresistance.
|
26286834 |
2016 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
IKBB, an inhibitor of NF-κB, has recently been shown to be inversely associated with tumor growth and metastasis via inactivation of the NF-κB pathway, but its suppressive role is still only poorly understood.
|
26227166 |
2016 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, our findings suggested that miR-20a could promote activation of the NFκB pathway and downstream targets livin and survivin by targeting NFKBIB, which potentially contributed to GC chemoresistance.
|
26286834 |
2016 |
Nasopharyngeal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
IKBB is silenced in the majority of NPC tumor tissues in all stages.
|
26227166 |
2016 |
Wheezing
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
IL8-rs4073AT, VEGFA-rs833058CT, MBL2-rs1800450CT and IKBKB-rs3747811AT were associated with a significantly increased risk of developing wheezing (p = 0.02, p = 0.03, p = 0.05 and p = 0.0018), whereas CTLA4-rs3087243AG and NFKBIB-rs3136641TT were associated with a significantly reduced risk (p = 0.05 and p = 0.04).
|
25326706 |
2014 |
Chronic Obstructive Airway Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Significant associations to the binary COPD phenotype in both populations were seen for STAT1 (rs13010343) and NFKBIB/SIRT2 (rs2241704) (p<0.05).
|
20562129 |
2011 |
Epithelial ovarian cancer
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We used a case-control study to evaluate the association between single nucleotide polymorphisms (SNPs) in NFKBIA and NFKBIB (the genes encoding IkappaBalpha and IkappaBbeta, respectively) and risk of epithelial ovarian cancer.
|
19500386 |
2009 |
ovarian neoplasm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Considering the number of single-SNP tests performed and null gene-level results, we conclude that NFKBIA and NFKBIB are not likely to harbor ovarian cancer risk alleles.
|
19500386 |
2009 |
Malignant neoplasm of ovary
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Considering the number of single-SNP tests performed and null gene-level results, we conclude that NFKBIA and NFKBIB are not likely to harbor ovarian cancer risk alleles.
|
19500386 |
2009 |
Carcinoma, Ovarian Epithelial
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Considering the number of single-SNP tests performed and null gene-level results, we conclude that NFKBIA and NFKBIB are not likely to harbor ovarian cancer risk alleles.
|
19500386 |
2009 |
Invasive Streptococcus pneumoniae disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
To determine whether polymorphisms in NFKBIA, NFKBIB, and NFKBIE associate with susceptibility to invasive pneumococcal disease (IPD) and thoracic empyema.
|
17463416 |
2007 |
Hepatitis C
|
0.010 |
AlteredExpression
|
disease |
LHGDN |
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta.
|
15919917 |
2005 |
Celiac Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
The degradation of I kappa B beta in the cytosol and the reappearance in the nucleus indicated a persistent NF-kappa B activation in celiac disease.
|
12743709 |
2003 |